explore -WSS

explore

author：leisure time 2025-09-10 16:45:00 - browse：58

James Comer -- coverage from STAT — Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Cognito secures funding to test medical device for Alzheimer's

WSS

My yearlong odyssey to get my son’s ADHD medication covered

Eli Lilly, Pfizer, and others want in on the online prescription market

The real point of Kenneth Smith’s execution by nitrogen gas

Biden administration opens offers in Medicare drug price negotiations

Why doctors need education on FDA device approval process

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Wikipedia

explore

focus

United colonoscopy coverage change 'may cost lives,' doctors say

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Biden administration opens offers in Medicare drug price negotiations

After affirmative action ruling, medical educators look to 'holistic review'

Commercial surrogacy can be ethical, despite pope’s claims

In Memoriam: Notable people who died in 2023

Francis Collins on trust in science and how Covid communications failed

BioMarin wins approval for gene therapy to treat hemophilia A

New Ultima Genomics DNA sequencer can read genome for $100

focus

Biotech venture capitalists face new demands from investors

Biden administration opens offers in Medicare drug price negotiations

The surgeon had a dilemma only a Nazi medical text could resolve

Think you might have Covid

The tragedy of Johnson & Johnson’s Covid vaccine

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

entertainment

entertainment

leisure time

entertainment